Individual and composite study endpoints: separating the wheat from the chaff
Department of Quantitative Health Sciences; Meyers Primary Care Institute; Department of Medicine, Division of Cardiovascular Medicine
*Clinical Trials as Topic; Cost-Benefit Analysis; *Endpoint Determination; Humans; *Outcome Assessment (Health Care); Prospective Studies; *Research Design; Sample Size; Treatment Outcome
Clinical Epidemiology | Epidemiology | Health Services Research | Translational Medical Research
We provide an overview of the individual and combined clinical endpoints and patient-reported outcomes typically used in clinical trials and prospective epidemiological investigations. We discuss the strengths and limitations associated with the utilization of aggregated study endpoints and surrogate measures of important clinical endpoints and patient-centered outcomes. We hope that the points raised in this overview will lead to the collection of clinically rich, relevant, measurable, and cost-efficient study outcomes.
DOI of Published Version
Goldberg R, Gore JM, Barton B, Gurwitz J. Individual and composite study endpoints: separating the wheat from the chaff. Am J Med. 2014 May;127(5):379-84. doi: 10.1016/j.amjmed.2014.01.011.
The American journal of medicine
Goldberg RJ, Gore JM, Barton BA, Gurwitz JH. (2014). Individual and composite study endpoints: separating the wheat from the chaff. UMass Center for Clinical and Translational Science Supported Publications. https://doi.org/10.1016/j.amjmed.2014.01.011. Retrieved from https://escholarship.umassmed.edu/umccts_pubs/18